PEGS Europe meeting, Lisbon (Portugal), November 18-22th, 2019
Talk by Thibaut Angevin, PhD, Pieris Pharmaceuticals GmbH
Nov. 21 – 12:15 : “Establishment of a CHO Transient Expression Platform for Bispecific Fusion Protein Developability Assessment”
Talk by Thibaut Angevin, PhD, Pieris Pharmaceuticals GmbH
Nov. 21 – 12:15 : “Establishment of a CHO Transient Expression Platform for Bispecific Fusion Protein Developability Assessment”
Would you like to stay up to date on Transfection?
Click on YES to subscribe to our newsletter (few emails/year)!
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |